Latest Articles

Subject

Article
Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis
Rohit Bakshi, Ada Yeste, Bonny Patel, et al.

January 27, 2016
Clinical/Scientific Notes
Autopsy-proven demyelination associated with infliximab treatment
Michael J. Bradshaw, Bret C. Mobley, Jeffrey P. Zwerner, et al.

January 27, 2016
Article
Alemtuzumab long-term immunologic effectTreg suppressor function increases up to 24 months
Stefania De Mercanti, Simona Rolla, Angele Cucci, et al.

January 21, 2016
Article
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder
Margherita Nosadini, Gulay Alper, Catherine J. Riney, et al.

January 21, 2016
Article
Mycoplasma pneumoniae, a trigger for Weston Hurst syndrome
Rick Magun, Chris P. Verschoor, Dawn M.E. Bowdish, et al.

January 21, 2016
Article
Lipocalin-2 is increased in progressive multiple sclerosis and inhibits remyelination
Faiez Al Nimer, Christina Elliott, Joakim Bergman, et al.

January 07, 2016
Article
Humoral response to EBV is associated with cortical atrophy and lesion burden in patients with MS
Robert Zivadinov, Nicole Cerza, Jesper Hagemeier, et al.

January 07, 2016
Clinical/Scientific Notes
The severe side of the IgG4-related hypertrophic pachymeningitis disease spectrum
Ryan D. Schubert, Matthew Wood, Marc H. Levin, et al.

January 07, 2016
Article
HLA-DRB1*14 is a protective allele for multiple sclerosis in an admixed Colombian population
Jaime Toro, David Cuellar-Giraldo, Camilo Díaz-Cruz, et al.

December 24, 2015
Article
¹H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis
Eleonora Cocco, Federica Murgia, Lorena Lorefice, et al.

December 24, 2015

Pages